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Abstract As genetics and genomics become part of main-
stream Medicine, these advances have the potential to reduce
or exacerbate health disparities. Gaps in effective communica-
tion (where all parties share the same meaning) are widely
recognized as a major contributor to health disparities. The
purpose of this study was to examine GC-patient communica-
tion in real time, to assess its effectiveness from the patient
perspective, and then to pilot intervention strategies to improve
the communication. We observed 64 English-, 35 Spanish- and
25 Chinese-speaking (n = 124) public hospital patients and 10
GCs in 170 GC appointments, and interviewed 49 patients who
were offered testing using the audio recordings to stimulate
recall and probe specific aspects of the communication. Data
analyses were conducted using grounded theory methods and
revealed a fundamental mismatch between the information pro-
vided by GCs and the information desired and meaningful to
patients. Several components of the communication that con-
tributed to this mismatch and often resulted in ineffective com-
munication included: (1) too much information; (2) complex
terminology and conceptually difficult presentation of informa-
tion; (3) information perceived as not relevant by the patient; (4)
unintentional inhibition of patient engagement and question-
asking; (5) vague discussions of screening and prevention rec-
ommendations. Our findings indicate a need to transform the
standard model of genetic counseling communication using
evidence-based principles and strategies from other fields of
Medicine. The high rates of limited health literacy in the US,
increasing access of diverse populations to genetic services, and
growing complexity of genetic information have created a per-
fect storm. If not directly addressed, this convergence is likely
to exacerbate health disparities in the genomic age.
Keywords Health communication . Patient-provider
communication . Hereditary cancer . Disparities .
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Introduction
As genetics and genomics become part of mainstream
Medicine, these advances have the potential to reduce or exac-
erbate health disparities. Hereditary cancer services are becom-
ing more accessible to a broader cross-section of the US pop-
ulation as criteria for cancer genetic services expand, insurance
coverage increases, and costs go down. Yet access alone is not
sufficient to ensure high quality GC and appropriate testing.
Gaps in effective communication (where all parties share the
same meaning) are widely recognized as a major contributor to
health disparities (US Department of Health and Human
Services, Office of Disease Prevention and Health Promotion
2000; Ad Hoc Committee on Health Literacy for the Council
on Scientific Affairs, American Medical Association 1999;
Andrus and Roth 2002; Williams 1995).
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Thirty-six percent of Americans have limited health litera-
cy (LHL), meaning they have below basic (no more than the
most simple and concrete literacy skills) or basic (skills nec-
essary to perform simple and everyday literacy activities) lit-
eracy (Kutner et al. 2006; Nielsen-Bohlman et al. 2004). Poor
health literacy (HL) is a stronger independent predictor of a
person’s health than age, income, employment status, educa-
tion level, and race/ethnicity (Berkman et al. 2011;Weiss et al.
2005). Patients with limited English proficiency (LEP), and
the elderly, poor, less educated, Latino or African American,
and those on Medicaid or Medicare are more likely to have
LHL, and the combination of LHL and LEP are synergistic
with respect to patients’ experiences of communication
(Kutner et al. 2006; Rudd 2007; Sudore et al. 2009).
Individuals with LHL are less likely to actively participate in
health care decision-making discussions, and more likely to
struggle with health management tasks including navigating
the health care system (Martin and Parker 2011). Importantly,
HL is promoted by accommodating or matching provider
communication with patient communication capacities
(Brach et al. 2012, 2014).
The urgency to address literacy, language and culture in
genetics and genomics communication has never been greater.
The National Human Genome Research Institute 2013 report
on the status of genomics literacy of the US defined genomic
health literacy (based on the IOM health literacy definition;
Nielsen-Bohlman et al. 2004) as the capacity to obtain, pro-
cess, understand, and use genomic information for health-
related decision-making. The authors identified genomic liter-
acy as necessary to realize the promise of Genomic Medicine
(Hurle et al. 2013).
While disparities in awareness and receipt of genetic test-
ing for Hereditary Breast and Ovarian Cancer (HBOC) have
been well documented (Butrick et al. 2015; Cragun et al.
2015; Mai et al. 2014; Walcott et al. 2014), relatively little
research has been conducted on the communication of genetic
counselors (GCs) or other genetics professionals with under-
served patients (Ellington et al. 2007; Erby et al. 2008; Lea
et al. 2011; Roter et al. 2007), and the potential impact of
communication on disparities in the translation of genomic
medicine (Forman and Hall 2009). Notable exceptions sug-
gest that culturally tailored communication may increase
awareness of genetic risk and satisfaction among African
American women (Charles et al. 2006), and communication
effectiveness with Chinese Australians (Barlow-Stewart et al.
2006). Research with Latino patients in prenatal genetics iden-
tified confusion and misunderstanding due to non-directive
communication, jargon, inadequate translation, patient mis-
trust, excess cultural sensitivity, and untested formats for pre-
senting risk information (Browner et al. 2003; Eichmeyer
et al. 2005; Penchaszadeh 2001; Rapp 1993). Studies of GC
literacy indicate that the literacy demands of genetic counsel-
ing may paradoxically reduce knowledge and satisfaction;
however these studies were conducted with simulated GC
sessions rather than actual visits (Erby et al. 2008; Lea et al.
2011; Roter et al. 2007).
To our knowledge, ours is the first study to examine the
communication between GCs and low income, ethnically and
linguistically diverse patients as they undergo cancer risk
counseling (Meiser et al. 2008; Paul et al. 2015). The purpose
of our study was to examine GC-patient communication in real
time and to assess its effectiveness from the patient perspective.
Methods
We used multiple inductive methods, including standard eth-
nographic techniques to conduct systematic observations de-
signed for minimal disruption of usual routines (Atkinson and
Hammersley 1994; Denzin and Lincoln 1998; Johnson and
Sackett 1998). We audio-recorded GC sessions, and conduct-
ed stimulated recall interviews with observed patients who
were offered testing (Lyle 2003; O’Brien et al. 2008).
Additional methods used but not reported on here, include
semi-structured interviews with observed GCs and healthcare
interpreters, and pilot testing of strategies to improve GC com-
munication. All research procedures for this study were ap-
proved by appropriate Institutional Review Boards. In accor-
dance with our IRB approved protocol, all proper names are
pseudonyms, and we have changed potentially identifying
characteristics to protect individuals’ identities.
Settings
Over 30 months (November 2012 – April 2015), we conduct-
ed direct observations at two public county hospitals in large
metropolitan areas of California where nearly all patients have
Medicaid orMedicare or are uninsured.Masters level licensed
GCs provided counseling and testing, which was available to
patients free of charge through a variety of means, including
Medi-Cal (California’s Medicaid program), Medicare, county
health programs, laboratory hardship programs and founda-
tion support.
At Site 1, GCs who specialize in cancer see patients inde-
pendently. Patients are referred through community clinics and
the hospital’s mammography, primary care, and oncology
clinics. GCs typically see a patient two or three times: (1) a
pre-test appointment to discuss family history, assess risk, and
educate about hereditary cancer and genetic testing; (2) a sec-
ond pre-test appointment to update pedigree with additional
information if requested by the GC, review risk assessment
and pre-test education, and draw blood/collect saliva; (3) a
results appointment to discuss implications of test results for
patient and family, and screening/prevention options. Some
positive patients also return for a follow-up appointment.
Medical interpretation is provided remotely by phone or video.
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At Site 2, GCs are generalists who see patients with the
support of an MD geneticist who was sometimes consulted
during the visit or joined the GC for part of the visit. Patients
are referred through oncology and primary care. GCs typically
see patients for a pre-test appointment to assess risk and draw
blood, and call the patient with test results. Patients with pos-
itive or variant of uncertain significance (VUS) results are
invited for an in-person follow-up appointment. Medical in-
terpretation is provided remotely by phone.
Participant Eligibility and Data Collection Procedures
All English-, Spanish- and Chinese-speaking patients who
had appointments when a language concordant researcher
was available were eligible for inclusion in the study.
Therefore, some eligible participants may not have been of-
fered the opportunity to participate. Initially, the study focused
on patients being counseled for HBOC, but as the testing
environment changed with the advent of panels after the
June 2013 Supreme Court decision overturning the Myriad
patent (Association for Molecular Pathology v. Myriad
Genetics), we expanded our criteria to include patients
suspected of having Lynch and other hereditary cancer syn-
dromeswhowere frequently being offered the same panel test.
Except for the occasions when a patient declined participation
or asked not to be recorded, the researcher directly observed
and audio-recorded patient-genetic counselor appointments.
Spanish and English speakers rarely declined to be audio re-
corded; in contrast, 12 of 40 observed Chinese participants did
not consent to be recorded. The researcher took detailed field
notes to record the dynamics of each session, communication
challenges, emotional tenor, body language, etc. (Emerson
et al. 1995). We obtained verbal consent from counselors
and patients for all observations and written consent for all
interviews.
After the initial visit, all observed patients who were of-
fered genetic testing were invited to complete a semi-
structured interview using stimulated recall (Lyle 2003;
O’Brien et al. 2008). We continued to observe and conduct
interviews until reaching theoretical saturation (Glaser and
Strauss 1967). Interviews were conducted as soon as possible
after the appointment (median = 8 days). Observation
fieldnotes and audio recordings were used to tailor the inter-
view guide which included the following general topics: (1)
experience with GC and testing; (2) understanding of inheri-
tance and beliefs about the causes of breast cancer; (3) cancer
risk perceptions; (4) understanding of test results and screen-
ing recommendations; and (5) personal history and sociocul-
tural and socioeconomic context of daily life. Audio excerpts
were used in each interview for stimulated recall (unless audio
recording had been declined). We selected standard elements
of the GC communication such as the explanation of genes,
heredity, BRCA, possible test results, and implications of test
results for patient and family, as well as excerpts where pa-
tients actively participated or were non-responsive in order to
probe patients’ understanding or thinking. The number of ex-
cerpts varied according to the content of the session and the
patient’s stamina and patience with reviewing the audio re-
cording (range 6–17).
At the end of each initial interview, we administered a short
demographic survey and the Subjective Numeracy Scale
(SNS) (Fagerlin et al. 2007; Zikmund-Fisher et al. 2007).
SNS is an 8-item scale that measures self-perceived ability
to perform mathematical tasks (e.g. calculating a tip) and pref-
erence for numerical rather than prose information. Each ques-
tion is scored on a 6-point Likert-like scale, and the overall
score is computed as the average rating across all eight ques-
tions. The SNS has been validated in English (Zikmund-
Fisher et al. 2007); we used a professional translation of it
for Spanish and Chinese speakers. We invited patients for a
second interview after their results appointment using the
same procedures. In appreciation of their time, respondents
received a $25 gift card for the first interview, and a $35 gift
card for the second interview.
Data Analysis
We calculated demographic characteristics and SNS for inter-
view participants. As a first level of analysis, prior to each
qualitative interview, the interviewer reviewed observation
field notes and the audio recording to identify appropriate
excerpts for stimulated recall and to tailor the interview guide
accordingly. Audio recordings of interviews, including the
segments of observations played during the interviews, were
professionally translated/transcribed, and transcripts were en-
tered into the qualitative analysis software Atlas-ti 7 for cod-
ing. We followed standard techniques based in grounded the-
ory, including iterative data review, and use of multiple coders
to identify the themes described and illustrative quotes includ-
ed below (Bernard 2006; Glaser and Strauss 1967; Strauss and
Corbin 1990). Each transcript was read by three members of
the research team and coded by at least two who also wrote
interim analytic memos. Coders independently reviewed the
initial transcripts using a combination of open coding and a
priori codes based on the interview guide, the literature,
and preliminary research (Joseph and Guerra 2015).
Coders then met to reconcile discrepancies and establish
a codebook. Examples of commonly used codes include:
GC explanation of possible test results; GC explanation
of screening/prevention options; patient information
needs; patient understanding of genetic test; patient under-
standing of screening/prevention options. Subsequently,
coders independently coded using the codebook, and then
met to reconcile discrepancies, discuss adding new





We observed English- (64), Spanish- (35) and Chinese-
speaking (25) patients (n = 124, plus 24 accompanying family
members) during 170 GC sessions with 10 GCs at the two
sites. Sessions included pre-test, results and results follow
up appointments. We invited all 49 patients who were
offered testing to participate in an interview, and all
accepted either after the pre-test or results appointment.
(See Table 1). We conducted 58 post-visit interviews
with the 49 patients; 35 were conducted after a pre-
test appointment; 23 after a results appointment. All
but four patients who were offered genetic testing ac-
cepted the test. Nine received positive results; five re-
ceived a variant of uncertain significance, and 31 tested
negative.
Demographic characteristics of the interviewed patients are
in Table 2. Chi-square tests showed significant differences in
educational level by language group. Of the English-speaking
participants, 70.6% had some college education or above
compared with 37.5% of the Spanish-speaking participants
and 16.7% of the Chinese-speaking participants. A one-way
ANOVA revealed that the overall Subjective Numeracy Scale
(SNS) scores (average rating across all 8 items) differed sig-
nificantly by language group, F (2, 44) = 3.28, p < .05
(Table 2). Tukey’s HSD (honest significant difference) tests
showed that English-speaking participants had higher scores
than Spanish-speaking participants, indicating that
English-speaking participants perceived higher ability
to perform various mathematical tasks and preferred
the use of numerical information over prose. English-
and Chinese-speaking participants did not significantly
differ in overall SNS scores. For comparison, in the
original scale development article, Fagerlin et al. (2007) re-
ported an average score of 4.03 (SD = 1.04; range = 1.00 to
6.00) in a sample with higher levels of education (72% self-
identified asWhite, 52% had some college, 10% had at least a
bachelor’s degree).
Table 3 shows demographic characteristics of ob-
served GCs. Observed pre-test GC appointments lasted
25–75 min with an average of 45–53 min depending on
language and site. The majority of each session consisted of
obtaining the family history and education about hereditary
cancer and genetic testing, while counseling and psy-
chosocial support typically constituted a minor portion of
the session.
Table 1 Study sample






















Individual patients observed 64 35 25 124
Observed patients offered
testing/declined testing
17/3 20/1 13/0 50/4
Interviewed/Interviews
(including test decliners)
16/17 20/24 13/17 49/58
Interviewed after
Pre-test 11 15 9 35
Result 6 9 8 23











b25 Breast (incl DCIS)
c3 ovarian
1 each melanoma, colon, rectal
16 unaffected
Test results
Positive 3 3 3 9 (6 BRCA; 2 Lynch; 1 ATM)
Negative 10 16 5 31
VUS 0 0 5 5
Not tested 3 1 0 4
a 37 Cantonese, 2 Mandarin, 1 Toisanese
bOne had breast and lung













Mean (SD) or n (%)
aAge 49.44 (13.72) 42.80 (11.22) 55.75 (12.78) 48.25 (13.29)
Marital status
Married/with a long-term partner 6 (37.5) 13 (65) 10 (76.9) 29 (59.2)
Never married 4 (25) 1 (5.0) 0 (0) 5 (10.2)
Legally separated or divorced 4 (25) 5 (25.0) 0 (0) 9 (18.4)
Widowed 1 (6.3) 1 (5.0) 1 (7.6) 3 (6.1)
Unreported/missing 1 (6.3) 0 (0) 2 (15.4) 3 (6.1)
Highest level of education
Less than high school 1 (6.3) 10 (50.0) 5 (38.5) 16 (32.7)
High school or equivalent 3 (18.8) 3 (15.0) 4 (30.8) 10 (20.4)
Some college or higher 11 (68.8) 7 (35.0) 2 (15.4) 20 (40.8)
Other (vocational school) 0 (0) 0 (0) 1 (7.6) 1 (2.0)
Unreported/missing 1 (6.3) 0 (0) 1 (7.6) 2 (4.1)
aSubjective Numeracy
Range 2.38–5.50 1.00–5.75 1.63–5.13 dF = 3.28
Mean (SD) 4.23 (0.86) 3.12 (1.61) 3.66 (1.06)
Race/ethnicity
African American 2 (12.5) 0 (0) 0 (0) 2 (4.1)
Chinese 0 (0) 0 (0) 13 (100) 13 (26.5)
bHispanic/Latino 1 (6.3) 19 (95.0) 0 (0) 20 (40.8)
White 11 (68.8) 1 (5) 0 (0) 12 (24.5)
cOther 2 (12.5) 0 (0) 0 (0) 2 (4.1)
U.S. born
Yes 11 (68.8) 1 (5.0) 0 (0) 12 (24.5)
No 4 (25.0) 19 (95.0) 13 (100) 36 (73.4)
Missing 1 (6.3) 0 (0) 0 (0) 1 (2.0)
Years in the U.S. (if foreign-born; n = 35)
Range 12–52 5–30 1–37 1–52
Mean 36 14.8 14.8 17.24
Language(s) Spoken at home
Only non-English/More non-English
language than English
5 (31.3) 18 (90.0) 13 (100.0) 36 (73.5)
Both equally 0 (0) 2 (10.0) 0 (0) 2 (4.1)
eOnly English/more English than
non-English language
11 (68.8) 0 (0) 0 (0) 11 (22.4)
Preferred Language with your doctor and nurses
English 13 (81.3) 4 (20.0) 0 (0) 17 (34.7)
Spanish 1 (6.3) 16 (80.0) 0 (0) 17 (34.7)
Cantonese/Mandarin 0 (0) 0 (0) 13 (100.0) 13 (26.5)
English/another non-English language 2 (12.5) 0 (0) 0 (0) 2 (4.1)
aMissing n = 1 Chinese
b BHispanic/Latino^ included 6 Hispanics/Latinos, 9 Mexicans, 2 Nicaraguans, and 3 Salvadorans
c BOther^ includes 1 Filipino and 1 White/American Indian
d p < .05




Through analysis of the observations and interviews, we iden-
tified a fundamental mismatch of patient information needs and
information provided by counselors (Table 4). Here we de-
scribe several components of the communication that contrib-
uted to this mismatch, along with illustrative quotes from our
patient interviews. These components often resulted in ineffec-
tive communication: (1) too much information; (2) complex
terminology and conceptually difficult presentation of informa-
tion; (3) information perceived as not relevant by the patient;
(4) unintentional inhibition of patient engagement and question
asking; (5) vague discussions of screening and prevention rec-
ommendations. Quotes are labeled with the participant’s lan-
guage (ENG, SP, CH), interview number and Pre-test or
Results to indicate which appointment preceded the interview.
1. Too much Information
A key component of the mismatch we identified was in
the amount of information patients wanted compared with
what GCs provided. While GCs are trained to provide
education about genetics, we found that in the context of
long explanations of heredity, genetics and genetic test-
ing, counselors’ key messages often got lost and patients
felt overwhelmed. In the following example, the GC of-
fered Bbackground^ information that involved technical
terminology (genes, cells), an analogy (Ba gene is like an
instruction book^), and complex scientific concepts (cell
growth, death and regulation, tumor versus normal cells).
(Audio Playback of Counseling Session during
Interview)
Table 3 Demographics of observed genetic counselors
Site Gender Race/Ethnicity Years in practice
(range)
Total






3 months - 25 years 7
Total 10
Table 4 Mismatch of information provided by genetic counselors and desired by patients
Information Provided to Counselors: What Patients Want to Know:
What genetics, genes and mutations are Is my cancer hereditary (does it run in the family 
and can it be passed on)?
How risk assessment is made Am I going to get cancer? Will my cancer come 
back?
What a genetic test is: how it is performed 
and what it examines
Are my family members (esp. children) going to 
get cancer?
Possible test results and limitations of test What caused my cancer?
aThere are things patient and family members 
can do –screening and surgery—if you “test 
positive”
If I am likely to get cancer (again), what can I do, 
if anything to protect myself? /What can I do, if 
anything to protect my children and other family 
members
a Shaded area indicates overlap between patient information needs and the information 
counselors provided.
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GC: We have our genetic material in our body and we
have, we actually have two copies of every gene, a gene
being an instruction that keeps our body working prop-
erly, the cells working properly.When they need to, they
make new cells or when they need to die, they die. So,
cells are normally dying and growing at one time. So
there are certain genes that regulate that process, that
make sure that the cells grow and die at the right time
and they don't form tumor cells.
(Interview)
Interviewer: What did you understand about that?
Participant: I just understood about the genes, that we
only have two genes and how some eventually die and
how one can still function with one. That's all that I
really understood. [ENG/SP-26; GC conducted in
English/Interview in Spanish; Pre-test].
Rather than clarifying, the background information con-
fused the patient and obscured the main point that the GC
wanted to convey about how cancer may be inherited.
Patients also indicated that information overload during
GC not only undermined understanding, but also could im-
pede decision-making. In the following case, this bilingual
40 year old with breast cancer was too overwhelmed to decide
about having the test. She ultimately agreed after significant
encouragement by the GC.
(Audio Playback of Counseling Session during
Interview)
GC:…so if it's something that you're interested in, we
could get it started today. But if it's something that you
don't know if you would be interested in, you could take
time to think about it. Okay?
Patient: I like [to] take time to think about it.
GC: Okay, you're not sure if you want the test, the blood
test?
Patient: Mm-hm.
GC: Okay. Tell me more. Tell me what–what are your
thoughts?
Patient: The only problem is I don't like–I don't like the
needles, so I just been like two times yesterday, today.
So, I don't want no more today.
GC: Okay.... how important is this kind of information
to you, though? Like to know if there is a genetic reason
why you have cancer?
(Interview)
Interviewer: What were you thinking there when she
asked you that?
Patient: Well, I didn't know how important because the
truth is– all of this was just like– Ah! Too much informa-
tion sometimes. So really... I knew and I know that it is
important, but at that moment it was like, this is too much
right now. Let me go home. [ENG/SP-65 Pre-test].
2. Complex Terminology and Conceptually Difficult
Presentation of Information
The complex terminology used by GCs and the use of
conceptually complex linguistic constructions like analogies
and hypotheticals contributed to patients’misunderstanding
and overwhelm. GCs used many specialized terms, includ-
ing Bgenes^, Bhereditary ,^ BBRCA^, Bchromosome^,
Bdeleterious^, Bgenetic factors^, Bpredisposition^, Brisk^,
Bsporadic^, Bmutation^, and Bvariant^. Even Bgenetic
counselor^ was a confusing term for many who had never
heard it prior to being referred. BMutation^ presented par-
ticular challenges. Although counselors described
Bmutation^ as a Bchange in a gene,^ and then used the term
interchangeably with Bchange,^ many patients did not un-
derstand it. In the context of breast cancer treatments in
which mastectomy can easily be perceived as a form of
mutilation, several Spanish speakers confused the less fa-
miliar Bmutation^ with the more familiar Bmutilation^
(mutación vs. mutilación). This 62 year-old bilingual
Latina struggled with the technical terminology.
I really didn't pick up too much. I just feel that some-
times doctors go in and they're using all these words and
stuff. No. Tell me layman’s terms, because I'm not
dumb, but something like that I don't really understand.
[28-ENG/SP Pre-test]
In her interview, it was evident that this patient understood
only the most basic information the GC had provided, and was
only interested in knowing if her children would inherit her
cancer.
To explain the limitations of testing an unaffected individ-
ual who was referred due to family history, counselors often
used hypothetical scenarios to describe why another relative
might be a Bmore informative^ person to test. In the following
case, this 28 year-old patient’s mother had died of breast can-
cer in their home country of Nicaragua when the patient was a
baby. (B(Interpreter)^ indicates a point in the conversation
where the GC paused to allow the medical interpreter to trans-
late the counselor’s speech into Spanish).
Audio Recording:
GC: …The best way for us to figure out if it’s genetic
would have been to actually test your mom and look at
her two BRCA genes (Interpreter) and that would tell us,
does she have a change in those genes that had contrib-
uted to her breast cancer? But because she is not alive
that’s not a test we can obviously do. (Interpreter) So
what we will do is we will go ahead and look at your
BRCA1 and BRCA2 genes. (Interpreter) If we see a
mutation then we would just make the assumption that
you had inherited that mutation from your mother.
(Interpreter) So, if your test comes back normal, meaning
Information Mismatch
both genes are just the way they're supposed to be, there's
no mutation, that's good news. But we still, interpret that
with a little bit of caution. (Interpreter) …let's say your
mom did have a mutation on one of these genes, let's say
BRCA1 gene, we have two copies of every gene, because
we get one from our mother and one from our father.
(Interpreter) So if your mother carried a copy of this gene
with a mutation, every time she'd have a child, it's a fifty-
fifty chance whether she passed on the copy that causes
the higher risk of cancer, or the normal copy...
(Interpreter).
Interview:
Participant’s Boyfriend: Did you understand?
Participant: That I could or could not have [cancer].
Participant’s Boyfriend: Yes. It's fifty-fifty. 50% that you
have cancer, or 50% that you don't. But actually the, the
test they did on you of the RCA1 and RCA2 means that
because of that you won't get cancer, but you could get it
for some other reason. Fifty percent for some other rea-
son. [SP-20 Results].
While the counselor intended to convey the limitations of
testing an unaffected individual, the use of the hypothetical
with attendant conditional tense and abstract possible future
scenarios was confusing. The patient’s boyfriend struggled to
understand what the 50/50 risk signified. The patient, fearing
that she already had cancer, and with little formal education,
had no context to make sense of the explanation of genetics
and believed the test was diagnostic. Her main concern, as
expressed in her interview, was not addressed in a way she
understood: BI want to know if I’m going to die or not.^
While working through a medical interpreter could amplify
the difficulty of such conversations, this complexity could be
confusing for English speakers with more education too, like
this 28 year old, college educated woman whose mother had
died of ovarian cancer.
Audio Recording
GC: So it’s true that the likelihood is that – you know,
almost nine out of ten ovarian cancers are not genetic.
They happen just by chance. And that would certainly
be the most likely given that there’s no other cancers, but
[your mother’s] family is kind of relatively small. So we
do …offer genetic testing to any individual who’s had
ovarian cancer even if there’s no family history just be-
cause of that kind of 5 to 10% chance that it would be
hereditary. And the guidelines also kind of say that it’s
appropriate to offer testing to an offspring of somebody
who’s had ovarian cancer if they’re no longer willing to
test.
Interview
Interviewer: Yes, there’s kind of a lot there. What’s your
reaction to all that or any of that?
Patient: Yeah, just getting more information, I suppose. I
still am like a little unclear. Like I remember feeling this
way in appointments and just kind of like being lost in like
a little bit of like what sounded like medical jargon, you
know, like stuff that I just – you know, if I hear a word that
I don’t recognize, I’m kind of like lost in the meaning of
the sentence, I suppose. But also just, yeah, gathering in-
formation about what the whole process is about and how
they select their candidates. [ENG-11 Pre-test].
In this case, the counselor’s attempt to explain her reason-
ing for offering the test, and emphasis on why the patient met
testing criteria distracted the patient and made it difficult to
focus on why the test might be useful for her.
In attempts to make abstract concepts more concrete, GCs
frequently used analogies (e.g., Bsequencing as a spellcheck^,
Bgenes like an instruction book^, Bflipping a coin^). While
some patients could relate to and understand these analogies,
for others lack of cultural or linguistic equivalence made them
meaningless. In the following example, themedical interpreter
anticipated the potential for confusion on the part of a
Spanish-speaking patient.
GC: The test they do, it's very much like a spell check
when you are writing a document on the computer or
maybe sending a text on your phone, it underlines the
words that are misspelled.
Interpreter: I don't know if you saw the computer, if you
use a computer, when you write something, the comput-
er corrects you if you write incorrectly. I don't know if
you have seen that.
Patient: No.
Interpreter: Okay. Well, what she is saying is that this is
a test in which later you can see on a screen like when
the computer corrects your misspellings.
Patient: Yes.
Interpreter: She has not seen that on the computer.
GC: Okay. But like on your phone, if you are texting
somebody...
Interpreter: But if you are sending a text message on the
telephone, I don't know if you do that either, but if you
are writing it corrects you automatically. I don't know if
you have seen that.
Patient: I never send texts.
Interpreter: She never sends texts.
Patient: I am far from civilization.
Interpreter: I am far away from civilization.
GC: Okay, all right. Well, basically this test it goes
through these genes and makes sure they're spelled cor-
rectly. [SP-29 Pre-test GC session].
Although the interpreter tried to guide her, the GC contin-
ued to try to use the spellcheck analogy. This patient never
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returned to the clinic after this appointment, and never
responded to our attempts to reach her for an interview.
3. Information Perceived as not Relevant by the Patient
As the previous two themes suggest, patients wanted infor-
mation that was simpler, narrower in scope, and more directly
relevant to their immediate situation than what GCs provided
(Table 4).Most importantly, theywanted information that they
could not only understand, but that was relevant to their per-
sonal context. For example, understanding chromosomes was
simply not important to this 62-year-old retired flight atten-
dant recently diagnosed with breast cancer.
And chromosomes. Those were really kind of fascinat-
ing but it wasn't something that I really wanted to see. I
just wanted to know how it [the test] was going to ben-
efit me… I think the bottom line is, I just want to know
at what percentage rate is it going to come back. [ENG-
33 Pre-test].
Importantly, this patient did not understand that the main
purpose of the test was to determine her risk for new cancers
of the breast and the ovary rather than risk of recurrence.
Similarly, a 46-year-old monolingual Cantonese speaker with
breast cancer said she only wanted to hear about the test re-
sults. She wasn’t interested in how the test works, what it
examines or how the GC makes her risk assessment. As a
result, that information did not Bstick^.
It wasn’t because of the interpreter, nor was it because
the topic was too complicated. It mainly depends on if I
think the information…has any impact on me. It’s like
when I take a test I only want to know the score. I don’t
care about anything else, plus I don’t even remember
those other things. …Anything else just doesn’t stick
in my mind. [CHI-16 Results].
The details about genetics were beyond her comprehension
and interest, and therefore not relevant to her treatment or
prevention decision-making. When asked later in the inter-
view about her understanding of Bmutation,^ she replied:
I only wanted to know the results. Yeah, I mean I don’t
understand these kinds of things. I don’t know what they
do inside. I can’t change that fact…I don’t know anything
about how genes mutate. They are inside our bodies. I
can’t control them and I don’t know what I can do.
There’s nothing I can do. [CHI-16 Results].
Again, the details about mutations and genes were of no
interest to her, given that they were beyond her understanding
and control.
4. Unintentional Inhibition of Patient Engagement and
Question-Asking
Despite not understanding much of what was said in
their GC appointments, many patients did not ask sub-
stantive questions, and counselors often were unable to
bridge this gap. While counselors frequently asked if pa-
tients had any questions, or if they were following the
explanation, these patients typically said they had no
questions or that they understood. For this bilingual
Latina, the GC’s pace and use of technical language led
her to believe she would not understand even if she asked
a question.
Patient:…Another thing, she can speak fast in English,
but how does she make sure we understood? Even if she
asks [if we understand], most likely we're going to say
Byes^. So the term genetics, medical terminology some-
times a person with less knowledge isn't going to under-
stand anything…my daughter and I have gone to school
and have a certain level of education…So, this is what I
can tell you really happened that day. Because I'm even
listening to it right now and I don't understand.
Interviewer: What was the reason that you didn't ask her
to, for example, repeat the information?
Patient: I didn't ask her to repeat the information because
even if she were to repeat it, I probably wouldn't have
understood again for the same reason because there is
vocabulary that's not in my, in my chip. (LAUGHS)
[SP-4 Pre-test].
Other patients did not ask questions because they did
not know what to ask or how to formulate the question.
During our interview with this Cantonese-speaking
70 year-old, she wondered why she got breast cancer
in the absence of a genetic mutation. Although the GC
asked if she had any questions, the patient had declined
to ask because she did not know how she was Bsupposed^ to
engage with a provider.
Patient: They said that I didn’t particularly have a great-
er chance than other people in getting cancer. The fact
that I did get cancer, is it because of my mood, the food
that I eat, the air that I breathe, or other factors? If that’s
true, then everyone has a chance of getting cancer.
Interviewer: Did you ask [the genetic counselor] this
question last time?
Patient: No. I didn’t know how to ask. Sometimes when
I’m asked if I have any questions, I do not know what
questions I’m supposed to ask. [CHI-11 Results]
Occasionally, when patients did ask questions, we some-
times observed that counselors provided indirect answers or
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attempted to explain the context, rather than answering direct-
ly and clearly, as in the case of this ATM carrier.
Audio Recording
Patient: Do you think, in my lifetime, what's the chance
that I'm going to–
GC: –Develop breast cancer? That's a great question.
Patient: Yes.
GC: So, twelve or thirteen percent is the average wom-
an. The one that you don't have that we were really
worried about was like the eighty, eighty-five percent
lifetime risk. For ATM carriers like you, it's about
twenty-five to thirty-five percent.
Interview
Interviewer: So, what does it mean the percentage that
she gave you, between twenty-five and thirty-five?
What does that number mean to you, to you?
Patient: Means that I have thirty-five percent of chance,
twenty-five, thirty-five percent to be in this case on the,
the pool, the gene pool of cancer. You know. That's what
I understood. She, she, she spoke very technically, you
know?
Interviewer: Mm-hm.
Patient: Like, if someone been trained. But I've not been
trained for that. So, yeah. She's supposed to be, be very
plain, simple. Of course facts, but more the language
that I understand. Not the language, you know. [ENG-
59 Results].
Although the counselor’s response was clearly intended to
contextualize the patient’s risk as between average population
risk and high risk, the patient, who spoke English as a second
language, found the explanation too technical.
5. Vague Discussions of Screening and Prevention
Recommendations
In contrast to much of the counseling content de-
scribed above, GCs and patients found more common
ground on the topic of risk reduction through screening
and prevention options for the patient and her family. Yet,
our interviews revealed that many patients left their re-
sults appointments with no clear understanding of what to
do next. For example, GCs frequently used general ter-
minology such as Bbreast exams^ which patients under-
stood asmammography, rather than the complete range of
exams including a clinical breast exam, mammography
and MRI that the GCs intended to convey. Patients often
forgot or did not completely understand recommenda-
tions for the age to start screening and the specific type
of screening for patients and their relatives.
One patient who had been diagnosed with Lynch syn-
drome did not understand the nature of the syndrome or
the difference between risk of metastasis and the risk of
new primary cancers; thus she saw no reason to undergo a
hysterectomy.
Patient: Right. She recommended that I removemy uter-
us, but I didn’t want to.
Interviewer: Why do you think she recommended you
to remove it?
Patient: Well if I remove it, then [the cancer] wouldn’t
go there. I didn’t think it was necessary, since it can go
anywhere. If it doesn’t go to the uterus, it will go to the
ovaries andmy ovaries are in the same area. I don’t think
it’s necessary. [9-CHI Results].
Other participants who did understand the recommendation
were not confident that they would be able to obtain the rec-
ommended care. One 30-year-old unaffected BRCA+ patient
explained how she felt about the counselor’s recommenda-
tions after her results appointment:
Walking away from the appointment, I was definitely
feeling overwhelmed and just the idea that I should find
a doctor who knows me and like gets to know me and I
can have this relationship with over these years.…I was
kind of thrown off by this idea of getting regular screen-
ings…I like the idea of doing that but it felt like intim-
idating or kind of impossible or that I would really need
to change my lifestyle to benefit my health in that way.
… Realistically I’ll probably just do it every year.
[ENG-17 Results].
She recognized that the recommended follow-up care, in-
cluding screening by alternating MRI and mammogram every
six months, presumed consistent access to health care and an
ongoing relationship with a provider, but she had never had
either. As a result, she was resigned to annual screening, rather
than the recommended six-month interval.
Discussion
This study of cancer risk counseling communication with di-
verse public hospital patients documented a mismatch be-
tween the information provided by counselors and what pa-
tients want and need to know.We found that patients preferred
less information overall than counselors typically delivered,
and they wanted it in a form that was less conceptually and
linguistically complex. The quantity and form of information
delivery unintentionally inhibited patient engagement and
question asking. As a result, patients’ fundamental questions
were sometimes left unanswered despite the counselors’ best
intentions. These findings reflect the experiences of English-,
Spanish- and Chinese-speaking participants in our study, even
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though English speakers had a higher educational level overall
compared with Spanish and Chinese speakers and higher SNS
than the Spanish speakers in our study.
The information mismatch suggests that counselors and
their diverse low-income patients are operating under different
assumptions when they meet in a counseling session. GCs are
trained and expected to provide genetics education to facilitate
informed decision-making about testing and risk reduction
(Doyle et al. 2016). In accord with their training, GCs as-
sumed that that they should explain how they make the risk
assessment, the underlying biology of cancer heredity, and the
technical process of genetic testing (Riley et al. 2012). These
assumptions reflect biomedical culture with its attendant ex-
citement about and immersion in the intricacies of genetic
science and the evolving, nuanced process of risk assessment
(Good et al. 2005;Weil 2000). In contrast, we found that many
patients were not interested in this level of detailed education
or the counselors’ underlying reasoning for their risk assess-
ment. Without interest, or the expectation that they would
understand the underlying science, they rarely asked for clar-
ification even when they did not comprehend what the coun-
selor was saying. Some assumed that the test would tell them
if they had cancer or the likelihood of a recurrence. Some also
seemed surprised when asked to make a decision about test-
ing. After a long discussion of family history and genetics, and
without a full discussion of the potential risks of testing, pa-
tients often assumed they would be tested rather than asked if
they wanted the test. This unexpected insertion of non-
directive communication could be confusing toward the end
of a long appointment. The mismatched assumptions were not
addressed adequately in the Bcontracting^ portion of the ses-
sion, and thus contributed to the mismatch of information.
As a result of the mismatch of information and assumptions,
patients often left counseling without a clear understanding of the
purpose and value of genetic testing or the recommended risk-
reduction practices. Under these circumstances, truly informed
consent for testing could not always be achieved, and important-
ly, the psychosocial and decision-making benefits of GC (Daly
et al. 2016) eluded some of these patients. Given the contribution
of ineffective communication to health disparities (Berkman
et al. 2011; USDHHS, ODPHP 2000), our findings raise con-
cerns that disparities documented in other aspects of hereditary
cancer services (Cragun et al. 2015; Levy et al. 2011; Mai et al.
2014) may be perpetuated by these communication barriers.
Despite the client-centered model of GC, prior research has
documented the high Boral literacy demand^ of GC (Roter
et al. 2007), and the dominance of informational and biomed-
ical talk and clinician dialogue (Meiser et al. 2008; Paul et al.
2015). Our data are consistent with these findings, but further-
more indicate that patients’ poor understanding and limited
engagement result from specific ways counselors present in-
formation, including the quantity of information, the lack of
context and relevance, and the conceptually difficult and
sometimes socio-culturally inappropriate hypothetical scenar-
ios and analogies. Patients’ inability to recall risk assessments
and screening recommendations is also consistent with prior
studies (Heshka et al. 2008); however, our data elucidate the
initial lack of understanding that limits recall.
Researchers and practitioners have begun to explore new
models of genetic counseling due to the shortage of genetic
counselors, the increasing demand for their services, and the
growing complexity of testing brought about by next generation
sequencing (Bradbury et al. 2015; Hooker et al. 2014). Some
have called for a shift away from a Bteaching model of
counseling^ and toward a Bpsychosocial model^ that allows
for more time counseling and less time educating (Biesecker
2016; Meiser et al. 2008). Our study suggests that to meet the
needs of the increasingly diverse patients who now have access
to genetic counseling and testing, any new model should incor-
porate the principles and strategies for effective communication
with LHL individuals developed and tested in other areas of
Medicine (Brega et al. 2015; USDHHS, ODPHP 2010).
Limitations
This study has limitations. It was conducted at only two public
hospitals in one state with a relatively small sample of coun-
selors. As a result, the communication barriers we documented
may be influenced by the practices of the participating coun-
selors and the cultures of the two institutions where they
worked. Nevertheless, the consistency in the content of the
counseling sessions and in the responses of the diverse patient
participants led us to identify strong patterns. Furthermore, the
counselor sample included graduates of five different GC train-
ing programs who were both longtime practitioners and rela-
tively new on the job. The presence of researchers during the
counseling sessions may have influenced counseling dynamics
in ways that we cannot know. Our interviews took place before
patients received any mailed follow-up letters, which might aid
understanding and/or recollection of key content from the GC
session. Although follow-up patient letters potentially could
mitigate some of the communication barriers we identified,
the timing and content of these letters varied across providers,
over the course of the study, and were not sent in all languages.
Our study primarily focused on documenting current commu-
nication dynamics and patients’ understanding and experience.
GCperspectives onworkingwith diverse, LEP andLHLpatients
also are critical for understanding the communication that we
documented between public hospital patients and genetic coun-
selors. For example, while several of the genetic counselors in
our study acknowledged that they sometimes wondered if their
patients understood all the information that they tried to convey,
they also admitted not knowing how to bridge the communica-
tion gap or how to confirm the patient’s understandingwhen they
suspected a problem (unpublished data). A full examination of
the perspectives of the GCs in our study is beyond the scope of
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this paper, but will be reported in a subsequent publication.
Cultural issues specific to Latina andChinese immigrant patients,
and communication challenges specific to medical interpretation
also will be described in subsequent publications.
Implications for Practice
Expanding testing criteria, health care reform, and reduced
costs are making counseling and testing available to many
more patients of LHL, LEP, and diverse cultural backgrounds.
Going forward, the All of Us Research Program (formerly
known as the Precision Medicine Initiative) and other NIH
initiatives that require inclusion of diverse populations in ge-
nomic research will expose broad segments of the US popu-
lation to genomic medicine. Although inequities in utilization
of cancer genetic testing persist (Armstrong 2005; Levy et al.
2011;McCarthy et al. 2016; Olaya et al. 2009; Pal et al. 2014),
studies show that there is interest in genetic services among
such diverse populations (Komenaka et al. 2016; Ramirez
et al. 2015; Ricker et al. 2006).
Given the findings of numerous studies regarding the liter-
acy demand of genetic counseling and poor retention of infor-
mation conveyed during genetic counseling (Roter et al. 2007;
Meiser et al. 2008; Paul et al. 2015), it is worth considering the
extent to which our findings might be relevant for all patients,
not just those of limited literacy. Only 12% of the US popu-
lation has proficient health literacy, meaning they can com-
plete tasks such as calculating an employee’s share of health
insurance costs using a table (Kutner et al. 2006; Nielsen-
Bohlman et al. 2004). Furthermore, health information and
the healthcare system can be difficult for highly skilled people
for a variety of reasons, including: the complexity of informa-
tion presentation; use of unfamiliar scientific and medical jar-
gon; demands of navigating the healthcare system, such as
locating providers and services and filling out forms.
Perhaps most important for the genetic counseling setting,
people of all literacy levels have difficulty understanding in-
formation when facing a new diagnosis or a stressful medical
situation (Kutner et al. 2006; USDHHS 2008). As such, the
Agency for Healthcare Research and Quality (AHRQ) sug-
gests using a BHealth Literacy Universal Precautions
Approach^ to making health information and healthcare con-
texts accessible for everyone (AHRQ 2015; DeWalt et al.
2011). This approach incorporates the principle of using plain
language. As Stableford and Mettger (2007) explain, the use of
plain language, which also has been endorsed by international
bodies (WHO, EuropeanCommission), is Bnot about Bdumbing
down^ information, writing in a condescending tone, or
neglecting the need for accuracy^ (p.79). Rather, it is about
clarity and meaning in written and oral communication.
The science of health communication has identified addi-
tional communication principles that are relevant for the prac-
tice of genetic counseling (Coleman 2011). First, the
responsibility for effective communication belongs to the cli-
nician, not the patient; it is the clinician’s responsibility to
meet the patient at his/her literacy level. Second, patients
may provide cues to their literacy level, and clinicians should
be trained to recognize these cues and adjust accordingly.
However, since it is not always possible to tell an individual’s
literacy level, the Universal Precautions Approach should be
used (AHRQ 2015). Third, adapting appropriately for limited
literacy requires commitment, sensitivity, flexibility, and
practice. Finally, patient comprehension can and must be ver-
ified (Coleman 2011; Schillinger et al. 2003; Sudore and
Schillinger 2009). Evidence-based communication strategies
using these principles include limiting information to what the
patient needs to know and needs to do; using plain language;
using proven risk communication strategies (e.g. pictograms
rather than percentages); and employing Bteach-back^ to as-
sess patient comprehension in order to immediately adjust
message and terminology (Brega et al. 2015; Fagerlin et al.
2011; Nouri and Rudd 2015; Schillinger et al. 2003; Weiss
2007).
Our group has taken a three-pronged approach that ac-
knowledges the roles of the counselor, patient and medical
interpreter to improve cancer risk communication with diverse
patients across literacy, language and culture. We have devel-
oped (and are in the process of updating) tailored pre-
counseling educational materials to support patients coming
to genetic counseling with little or no prior knowledge of
counseling or testing (Joseph et al. 2010). In addition, we have
developed a training curriculum for healthcare interpreters in
cancer genetics (Lara-Otero et al. 2016; Roat et al. 2016) to
support interpreters’ continuing education in the field of ge-
netics. To aid counselors, we have begun to adapt to the cancer
GC context the evidence based communication strategies de-
scribed above and to test the feasibil i ty of their
implementation.
Conclusion
Our findings indicate a need to transform the standard model
of genetic counseling communication to adapt to the commu-
nication needs of patients. The high rates of LHL in the US,
increasing access of diverse populations to genetic services,
and growing complexity of genetic information have created a
perfect storm. If not directly addressed, this convergence is
likely to exacerbate health disparities in the genomic
age.
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